Skip to main content
OpenTrials

Clinical trial condition

Stage IV Renal Cell Cancer AJCC v8

Explore clinical trials studying Stage IV Renal Cell Cancer AJCC v8. Study availability and eligibility vary by location and protocol.

50 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Stage IV Renal Cell Cancer AJCC v8 trial results

Active, not recruiting

Cancer and Blood Pressure Management, CARISMA Study

NCT04467021

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +36 more
Locations
  • Siteman Cancer Center at West County Hospital Creve Coeur, Missouri, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
  • Montefiore Medical Center-Weiler Hospital The Bronx, New York, United States
View all 25 locations
View Trial Details
Active, not recruiting

Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study

NCT05863351

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
  • Poudre Valley Hospital Fort Collins, Colorado, United States
View all 108 locations
View Trial Details
Active, not recruiting

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

NCT06500455

Conditions
Adenocarcinoma, Anatomic Stage IV Breast Cancer AJCC v8, Brain Diseases, +52 more
Locations
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 270 locations
View Trial Details
Active, not recruiting

Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors

NCT02496208

Conditions
Adenocarcinoma, Bladder Small Cell Neuroendocrine Carcinoma, Bladder Squamous Cell Carcinoma, +54 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View Trial Details

Related conditions